Journal of Pharmacoeconomics and Pharmaceutical Management (Apr 2023)

Assessment of the Iran Action Plan against Antimicrobial Resistance

  • Shahrbano Shafian,
  • Zahra Sharif,
  • Leila Zarei,
  • Mohammad Hadidi,
  • Kamran Bagheri Lankarani

DOI
https://doi.org/10.18502/jppm.v9i1.12881
Journal volume & issue
Vol. 9, no. 1

Abstract

Read online

The Islamic Republic of Iran provided a national action plan against antimicrobial resistance (NAP/AMR) for 2016-2021. In this study, we have dealt with the background and Iran’s efforts in this way, compare Iran’s NAP/AMR with other international programs, represent efficient policy options, and the evaluation indicators of each purpose of Iran NAP/AMR. The indicators of each group are represented through the consensus of three academic researchers. Finally, our assessment reveals that performing a constant observation is highly required for a prearranged NAP/AMR. The political parties and stakeholders should punctually receive interpretable feedbacks; also, it is very important to conduct periodical assessments with the purpose of perceiving the purpose feasibility and determining the dimensions that require advancements.

Keywords